Ginkgo Bioworks
Boston · 1 people tracked
Investment thesis
Ginkgo Bioworks is a Boston-based biotechnology company that builds autonomous laboratory systems to automate manual benchwork in scientific R&D. Through its Ginkgo Solutions and Ginkgo Datapoints teams, it designs and runs experiments for customers, letting scientists request lab work from robotic systems rather than performing it by hand. The company reports serving more than 130 customers.
Team · 1 people
from the firm's websiteFrequently asked questions
- What sectors does Ginkgo Bioworks focus on?
- Ginkgo Bioworks focuses on Biotech.
- Where is Ginkgo Bioworks located?
- Ginkgo Bioworks is headquartered in Boston, US.
Similar investors
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
B Capital Group is a multi-stage venture capital firm that backs founders across the company-building lifecycle, investing in technology, healthcare, and energy & resilience sectors.